• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义人类癌症中的驱动 DNA 甲基化变化。

Defining Driver DNA Methylation Changes in Human Cancer.

机构信息

Center for Epigenetics, Van Andel Research Institute, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA.

出版信息

Int J Mol Sci. 2018 Apr 12;19(4):1166. doi: 10.3390/ijms19041166.

DOI:10.3390/ijms19041166
PMID:29649096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5979276/
Abstract

Human malignant tumors are characterized by pervasive changes in the patterns of DNA methylation. These changes include a globally hypomethylated tumor cell genome and the focal hypermethylation of numerous 5'-cytosine-phosphate-guanine-3' (CpG) islands, many of them associated with gene promoters. It has been challenging to link specific DNA methylation changes with tumorigenesis in a cause-and-effect relationship. Some evidence suggests that cancer-associated DNA hypomethylation may increase genomic instability. Promoter hypermethylation events can lead to silencing of genes functioning in pathways reflecting hallmarks of cancer, including DNA repair, cell cycle regulation, promotion of apoptosis or control of key tumor-relevant signaling networks. A convincing argument for a tumor-driving role of DNA methylation can be made when the same genes are also frequently mutated in cancer. Many of the most commonly hypermethylated genes encode developmental transcription factors, the methylation of which may lead to permanent gene silencing. Inactivation of such genes will deprive the cells in which the tumor may initiate from the option of undergoing or maintaining lineage differentiation and will lock them into a perpetuated stem cell-like state thus providing an additional window for cell transformation.

摘要

人类恶性肿瘤的特征是 DNA 甲基化模式的普遍改变。这些变化包括整个肿瘤细胞基因组的低甲基化和许多 5'-胞嘧啶-磷酸-鸟嘌呤-3'(CpG)岛的局灶性高甲基化,其中许多与基因启动子有关。将特定的 DNA 甲基化变化与因果关系中的肿瘤发生联系起来一直具有挑战性。一些证据表明,癌症相关的 DNA 低甲基化可能会增加基因组不稳定性。启动子的高甲基化事件可能导致在反映癌症特征的途径中起作用的基因沉默,包括 DNA 修复、细胞周期调控、促进细胞凋亡或控制关键的肿瘤相关信号网络。当相同的基因在癌症中也经常发生突变时,可以提出 DNA 甲基化在肿瘤驱动中的作用的令人信服的论点。许多最常被高甲基化的基因编码发育转录因子,其甲基化可能导致基因的永久沉默。这种基因的失活将剥夺肿瘤可能起始的细胞进行或维持谱系分化的选择,并将其锁定在持续的干细胞样状态,从而为细胞转化提供另一个窗口。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa2e/5979276/3b8300ca0569/ijms-19-01166-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa2e/5979276/6a2a36badf0e/ijms-19-01166-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa2e/5979276/73273b9d996d/ijms-19-01166-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa2e/5979276/3b8300ca0569/ijms-19-01166-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa2e/5979276/6a2a36badf0e/ijms-19-01166-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa2e/5979276/73273b9d996d/ijms-19-01166-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa2e/5979276/3b8300ca0569/ijms-19-01166-g003.jpg

相似文献

1
Defining Driver DNA Methylation Changes in Human Cancer.定义人类癌症中的驱动 DNA 甲基化变化。
Int J Mol Sci. 2018 Apr 12;19(4):1166. doi: 10.3390/ijms19041166.
2
DNA methylation and cancer.DNA 甲基化与癌症。
Adv Genet. 2010;70:27-56. doi: 10.1016/B978-0-12-380866-0.60002-2.
3
Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.甲基化CpG结合蛋白MBD2在癌症中CpG岛和海岸区域DNA甲基化的维持与扩散过程中发挥关键作用。
Oncogene. 2017 Mar;36(10):1328-1338. doi: 10.1038/onc.2016.297. Epub 2016 Sep 5.
4
Comparison of genome-wide analysis techniques to DNA methylation analysis in human cancer.比较全基因组分析技术与人类癌症中的 DNA 甲基化分析。
J Cell Physiol. 2018 May;233(5):3968-3981. doi: 10.1002/jcp.26176. Epub 2017 Oct 4.
5
Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.在癌症发展过程中,低甲基化与高甲基化呈拮抗协同作用:以白血病为例。
Hum Genomics. 2016 Jul 25;10 Suppl 2(Suppl 2):18. doi: 10.1186/s40246-016-0071-5.
6
Silencing of bidirectional promoters by DNA methylation in tumorigenesis.肿瘤发生过程中DNA甲基化对双向启动子的沉默作用。
Cancer Res. 2006 May 15;66(10):5077-84. doi: 10.1158/0008-5472.CAN-05-2629.
7
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.CpG岛高甲基化与肿瘤抑制基因:蓬勃的现在,更光明的未来。
Oncogene. 2002 Aug 12;21(35):5427-40. doi: 10.1038/sj.onc.1205600.
8
Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.通过表观基因组分析鉴定癌症中的驱动和乘客 DNA 甲基化。
Adv Genet. 2010;70:277-308. doi: 10.1016/B978-0-12-380866-0.60010-1.
9
Multifaceted Roles of DNA Methylation in Neoplastic Transformation, from Tumor Suppressors to EMT and Metastasis.DNA 甲基化在肿瘤发生、转化中的多效性作用:从肿瘤抑制因子到 EMT 和转移。
Genes (Basel). 2020 Aug 12;11(8):922. doi: 10.3390/genes11080922.
10
Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.全基因组DNA甲基化分析揭示了胰腺癌的分子亚型。
Oncotarget. 2017 Apr 25;8(17):28990-29012. doi: 10.18632/oncotarget.15993.

引用本文的文献

1
TC2N promotes the proliferation and invasion of head and neck cancer cells with the p53-R175H.TC2N通过p53-R175H促进头颈癌细胞的增殖和侵袭。
Transl Cancer Res. 2025 Jul 30;14(7):3905-3919. doi: 10.21037/tcr-24-2130. Epub 2025 Jul 27.
2
FOXP1 is associated with oncogenesis and clinical outcomes in hematologic malignancies.FOXP1与血液系统恶性肿瘤的肿瘤发生及临床结局相关。
Front Immunol. 2025 Jul 2;16:1569641. doi: 10.3389/fimmu.2025.1569641. eCollection 2025.
3
cfMethylPre: deep transfer learning enhances cancer detection based on circulating cell-free DNA methylation profiling.

本文引用的文献

1
Methylation profiling identifies two subclasses of squamous cell carcinoma related to distinct cells of origin.甲基化分析确定了与不同起源细胞相关的两种鳞状细胞癌亚类。
Nat Commun. 2018 Feb 8;9(1):577. doi: 10.1038/s41467-018-03025-1.
2
Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications.胶质母细胞瘤 CpG 岛甲基化表型(G-CIMP):生物学和临床意义。
Neuro Oncol. 2018 Apr 9;20(5):608-620. doi: 10.1093/neuonc/nox183.
3
TET-mediated active DNA demethylation: mechanism, function and beyond.TET 介导的活性 DNA 去甲基化:机制、功能及其他。
cfMethylPre:深度迁移学习基于循环游离DNA甲基化谱分析增强癌症检测。
Brief Bioinform. 2025 May 1;26(3). doi: 10.1093/bib/bbaf303.
4
Pan-cancer analysis identifies DBF4B as an immunologic and prognostic biomarker.泛癌分析确定DBF4B为一种免疫和预后生物标志物。
J Cancer. 2025 Jun 12;16(8):2626-2648. doi: 10.7150/jca.109134. eCollection 2025.
5
Identification and validation of a DNA methylation-block prognostic model in non-small cell lung cancer patients.非小细胞肺癌患者中DNA甲基化阻断预后模型的识别与验证
BMC Cancer. 2025 Jun 4;25(1):999. doi: 10.1186/s12885-025-14382-8.
6
Pan-cancer analysis shows that TRIP13 as a potential prognostic and immunotherapeutic biomarker for multiple cancer types including LIHC and LUAD.泛癌分析表明,TRIP13作为包括肝癌(LIHC)和肺癌(LUAD)在内的多种癌症类型的潜在预后和免疫治疗生物标志物。
Medicine (Baltimore). 2025 May 30;104(22):e42588. doi: 10.1097/MD.0000000000042588.
7
Multi-Omics Pan-Cancer Profiling of Unveils Its Prognostic Potential, Metabolic Regulation, and Immune Microenvironment Interactions.多组学泛癌分析揭示其预后潜力、代谢调控及免疫微环境相互作用。
Biology (Basel). 2025 May 19;14(5):567. doi: 10.3390/biology14050567.
8
DNA Methyltransferases 1-Regulated Methylation of Protein Kinase C Zeta Influences Its Expression in Breast Cancer Cells.DNA甲基转移酶1调控的蛋白激酶Cζ甲基化影响其在乳腺癌细胞中的表达。
J Breast Cancer. 2025 Apr;28(2):72-85. doi: 10.4048/jbc.2024.0201. Epub 2025 Feb 17.
9
Pan‑cancer analysis of oncogene SFXN1 to identify its prognostic and immunological roles in lung adenocarcinoma.癌基因SFXN1的泛癌分析,以确定其在肺腺癌中的预后和免疫作用。
Oncol Rep. 2025 Apr;53(4). doi: 10.3892/or.2025.8883. Epub 2025 Mar 7.
10
ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation.整合素α4(ITGA4)作为人类癌症潜在的预后和免疫治疗生物标志物及其在胃癌中的临床意义:一项整合分析与验证
Front Oncol. 2025 Feb 12;15:1513622. doi: 10.3389/fonc.2025.1513622. eCollection 2025.
Nat Rev Genet. 2017 Sep;18(9):517-534. doi: 10.1038/nrg.2017.33. Epub 2017 May 30.
4
APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review.APC基因高甲基化用于结直肠癌的早期诊断:一项荟萃分析及文献综述
Oncotarget. 2017 Jul 11;8(28):46468-46479. doi: 10.18632/oncotarget.17576.
5
DNA methylation and DNA methyltransferases.DNA甲基化与DNA甲基转移酶
Epigenetics Chromatin. 2017 May 8;10:23. doi: 10.1186/s13072-017-0130-8. eCollection 2017.
6
Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia.全基因组DNA甲基化分析揭示了早期结肠肿瘤中与癌症相关的变化。
Oncogene. 2017 Aug 31;36(35):5035-5044. doi: 10.1038/onc.2017.130. Epub 2017 May 1.
7
DNA methylation aberrancies as a guide for surveillance and treatment of human cancers.DNA甲基化异常作为人类癌症监测和治疗的指导
Epigenetics. 2017 Jun 3;12(6):416-432. doi: 10.1080/15592294.2017.1311434. Epub 2017 Mar 30.
8
Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes.通过激活癌胚基因导致的 DNA 低甲基化的致癌作用。
Cancer Lett. 2017 Jun 28;396:130-137. doi: 10.1016/j.canlet.2017.03.029. Epub 2017 Mar 22.
9
Intragenic DNA methylation prevents spurious transcription initiation.基因内 DNA 甲基化可防止假转录起始。
Nature. 2017 Mar 2;543(7643):72-77. doi: 10.1038/nature21373. Epub 2017 Feb 22.
10
Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.肝脏中的河马信号通路调控器官大小、细胞命运和癌症发生。
Gastroenterology. 2017 Feb;152(3):533-545. doi: 10.1053/j.gastro.2016.10.047. Epub 2016 Dec 19.